Literature DB >> 17407140

Overexpression of integrin beta1 inhibits proliferation of hepatocellular carcinoma cell SMMC-7721 through preventing Skp2-dependent degradation of p27 via PI3K pathway.

Yi Fu1, Zhengyu Fang, Yulong Liang, Xiaodong Zhu, Peterbram Prins, Zengxia Li, Liying Wang, Lidong Sun, Jiawei Jin, Yong Yang, Xiliang Zha.   

Abstract

Integrins may play important roles in many cellular events, such as cell proliferation, differentiation, and apoptosis. We showed previously that overexpression of integrin beta1 inhibits cell proliferation in SMMC-7721 cells. Here we reported that one of the cyclin-dependent kinase (CDK) inhibitors, p27(Kip1) was involved in proliferation-inhibition induced by overexpression of integrin beta1. Overexpression of integrin beta1 upregulated p27(Kip1) at the protein level, but not mRNA level. The knock-down of p27(Kip1) expression restored cell growth in integrin beta1-overexpressing cells. Cycloheximide (Chx) treatment and pulse-chase experiments revealed that overexpression of integrin beta1 prolonged the half-life of p27(Kip1) by inhibiting its degradation. Proteasome inhibitor (MG132) treatment of the cells indicated that proteasome mediated degradation of p27, and Skp2-dependent degradation might be prevented. Overexpression of integrin beta1 decreased Skp2 at mRNA level, which was regulated by cell adhesion and the subsequent adhesion-dependent signaling. Overexpression of integrin beta1 reduced cell adhesion, accordingly, inactivated the phosphoinositide 3-kinase (PI3K) signaling. PI3K inhibitor LY294002 upregulated p27(Kip1) at post-translational level and downregulate Skp2 at mRNA level, which could mimic the effects of integrin beta1 overexpression on p27(Kip1) and Skp2. Together, these results suggested that overexpression of integrin beta1 inhibited cell proliferation by preventing the Skp2-dependent degradation of p27(Kip1) via PI3K pathway. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17407140     DOI: 10.1002/jcb.21323

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

Review 1.  Environment-mediated drug resistance: a major contributor to minimal residual disease.

Authors:  Mark B Meads; Robert A Gatenby; William S Dalton
Journal:  Nat Rev Cancer       Date:  2009-08-20       Impact factor: 60.716

2.  In vitro characterization of uptake mechanism of L-[methyl-(3)H]-methionine in hepatocellular carcinoma.

Authors:  Yu Kuang; Fangjing Wang; David J Corn; Haibin Tian; Zhenghong Lee
Journal:  Mol Imaging Biol       Date:  2014-08       Impact factor: 3.488

3.  O-GlcNAcylation/phosphorylation cycling at Ser10 controls both transcriptional activity and stability of delta-lactoferrin.

Authors:  Stéphan Hardivillé; Esthelle Hoedt; Christophe Mariller; Monique Benaïssa; Annick Pierce
Journal:  J Biol Chem       Date:  2010-04-19       Impact factor: 5.157

Review 4.  The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.

Authors:  Ju Dong Yang; Ikuo Nakamura; Lewis R Roberts
Journal:  Semin Cancer Biol       Date:  2010-10-12       Impact factor: 15.707

5.  Laminin alters fyn regulatory mechanisms and promotes oligodendrocyte development.

Authors:  Jenne Relucio; Iva D Tzvetanova; Wei Ao; Sabine Lindquist; Holly Colognato
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

Review 6.  The tumor microenvironment is a dominant force in multidrug resistance.

Authors:  Ana Luísa Correia; Mina J Bissell
Journal:  Drug Resist Updat       Date:  2012-02-13       Impact factor: 18.500

7.  Metabolism of radiolabeled methionine in hepatocellular carcinoma.

Authors:  Yu Kuang; Fangjing Wang; David J Corn; Haibin Tian; Zhenghong Lee
Journal:  Mol Imaging Biol       Date:  2014-02       Impact factor: 3.488

Review 8.  The mesenchymal tumor microenvironment: a drug-resistant niche.

Authors:  Edna Cukierman; Daniel E Bassi
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

9.  Polarization and myelination in myelinating glia.

Authors:  Toshihiro Masaki
Journal:  ISRN Neurol       Date:  2012-12-30

10.  Inhibition of hepatocelluar carcinoma MAT2A and MAT2beta gene expressions by single and dual small interfering RNA.

Authors:  Qun Wang; Quan-yan Liu; Zhi-Su Liu; Qun Qian; Quan Sun; Ding-yu Pan
Journal:  J Exp Clin Cancer Res       Date:  2008-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.